• Aegerion Pharmaceuticals Inc., of Bridgewater, N.J., named Marc Beer CEO and board member.

• Agios Pharmaceuticals Inc., of Cambridge, Mass., appointed Scott Biller chief scientific officer.

• Allosterix Ltd., of Rehovot, Israel, appointed Aharon Ciechanover to its scientific advisory board.

• Alnylam Pharmaceuticals Inc., of Cambridge, Mass., elected Steven M. Paul to its board.

• AmStem Corp., of San Francisco, appointed Dwight Brunoehler president.

• Aquinox Pharmaceuticals Inc., of Vancouver, British Columbia, appointed Csaba Szabo vice president of research and chief scientific officer.

• AVEO Pharmaceuticals Inc., of Cambridge, Mass., appointed Michael P. Bailey chief commercial officer and Donna M. Radzik vice president of technical operations.

• Biodel Inc., of Danbury, Conn., appointed Arthur Urciuoli to its board.